Accuray (ARAY) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -97.79% |
| Dec 31, 2025 | -37.35% |
| Sep 30, 2025 | -123.63% |
| Jun 30, 2025 | 22.63% |
| Mar 31, 2025 | -20.06% |
| Dec 31, 2024 | -25.03% |
| Sep 30, 2024 | 15.82% |
| Jun 30, 2024 | 39.40% |
| Mar 31, 2024 | -39.89% |
| Dec 31, 2023 | -15.70% |
| Sep 30, 2023 | 20.25% |
| Jun 30, 2023 | 52.12% |
| Mar 31, 2023 | 15.64% |
| Dec 31, 2022 | 16.86% |
| Sep 30, 2022 | 10.30% |
| Jun 30, 2022 | 23.51% |
| Mar 31, 2022 | 26.95% |
| Dec 31, 2021 | 15.09% |
| Sep 30, 2021 | 36.46% |
| Jun 30, 2021 | 18.38% |
| Mar 31, 2021 | -20.26% |
| Dec 31, 2020 | 22.79% |
| Sep 30, 2020 | 15.22% |
| Jun 30, 2020 | 18.73% |
| Mar 31, 2020 | 23.60% |
| Dec 31, 2019 | 25.16% |
| Sep 30, 2019 | 15.45% |
| Jun 30, 2019 | 31.44% |
| Mar 31, 2019 | 23.98% |
| Dec 31, 2018 | 3.13% |
| Sep 30, 2018 | 9.93% |
| Jun 30, 2018 | 44.95% |
| Mar 31, 2018 | 22.27% |
| Dec 31, 2017 | 30.53% |
| Sep 30, 2017 | 17.22% |
| Jun 30, 2017 | 23.66% |
| Mar 31, 2017 | 19.50% |
| Dec 31, 2016 | 2.04% |
| Sep 30, 2016 | 17.84% |
| Jun 30, 2016 | 22.01% |
| Mar 31, 2016 | 21.54% |
| Dec 31, 2015 | -28.26% |
| Sep 30, 2015 | -22.93% |